The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

Schrödinger, Inc. (Nasdaq: SDGR) strongly supports the U.S. Food and Drug Administration’s (FDA) plan to reduce, refine or ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on “lab-grown human ‘organoids.'" ...

Animal experiments are widely used to develop new medicines and to test the safety of other products. Many of these experiments cause pain to the animals involved or reduce their quality of life ...

The Physicians Committee for Responsible Medicine, a nonprofit that advocates for nonanimal science, is applauding the new commissioner of the U.S. Food and Drug Administration, Marty Makary, MD, MPH, ...

Schrodinger (SDGR) said it supports the FDA’s plan to reduce, refine or potentially replace current animal testing requirements with new ...

A new undercover investigation by Last Chance for Animals (LCA) has exposed the disturbing abuse and suffering rats endure in a North American toxicology ... the experiments continued with no ...

Appropriately monitored and regulated animal experiments have been and still are necessary ... laboratory animals are not used for Testing cosmetic ingredients Toxicology testing Statutory drug safety ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...